Log in

OTCMKTS:WIZP - Wize Pharma Stock Price, Forecast & News

-0.09 (-27.27 %)
(As of 12/15/2019 01:42 PM ET)
Today's Range
Now: $0.24
50-Day Range
MA: $0.25
52-Week Range
Now: $0.24
Volume7,700 shs
Average Volume29,317 shs
Market Capitalization$2.64 million
P/E RatioN/A
Dividend YieldN/A
Wize Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the treatment of ophthalmic disorders. It has in-license rights to purchase, market, sell, and distribute LO2A for the treatment of dry eye syndrome (DES)and other ophthalmological illnesses, including Conjunctivochalasis (CCH) and Sjögren's syndrome (Sjögren's) in the United States, Israel, Ukraine, and China. The company markets LO2A products for the treatment of DES in Germany and Switzerland; DES and CCH in Hungary; and DES and Sjögren's in the Netherlands. It is developing LO2A, which is in Phase II trial for patients with CCH; and Phase IV study for DES in patients with Sjögren's. The company was formerly known as Star Night Technologies Ltd. and changed its name to Wize Pharma, Inc. in July 2015. Wize Pharma, Inc. was founded in 1982 and is headquartered in Hod Hasharon, Israel.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:WIZP



Sales & Book Value

Annual SalesN/A
Book Value$0.02 per share


Net Income$-3,280,000.00


Market Cap$2.64 million
Next Earnings Date4/6/2020 (Estimated)
OptionableNot Optionable

Receive WIZP News and Ratings via Email

Sign-up to receive the latest news and ratings for WIZP and its competitors with MarketBeat's FREE daily newsletter.

Wize Pharma (OTCMKTS:WIZP) Frequently Asked Questions

What is Wize Pharma's stock symbol?

Wize Pharma trades on the OTCMKTS under the ticker symbol "WIZP."

How were Wize Pharma's earnings last quarter?

Wize Pharma Inc (OTCMKTS:WIZP) announced its quarterly earnings data on Thursday, November, 14th. The company reported ($0.08) EPS for the quarter. View Wize Pharma's Earnings History.

When is Wize Pharma's next earnings date?

Wize Pharma is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for Wize Pharma.

Has Wize Pharma been receiving favorable news coverage?

News articles about WIZP stock have been trending somewhat negative on Sunday, according to InfoTrie Sentiment. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Wize Pharma earned a coverage optimism score of -1.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Wize Pharma.

Who are some of Wize Pharma's key competitors?

What other stocks do shareholders of Wize Pharma own?

Who are Wize Pharma's key executives?

Wize Pharma's management team includes the folowing people:
  • Mr. Or Eisenberg, Acting CEO, CFO, Treasurer & Sec. (Age 38)
  • Mr. Noam Danenberg, Chief Operating Officer (Age 49)

How do I buy shares of Wize Pharma?

Shares of WIZP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Wize Pharma's stock price today?

One share of WIZP stock can currently be purchased for approximately $0.24.

How big of a company is Wize Pharma?

Wize Pharma has a market capitalization of $2.64 million. The company earns $-3,280,000.00 in net income (profit) each year or ($0.61) on an earnings per share basis. Wize Pharma employs 1 workers across the globe.View Additional Information About Wize Pharma.

What is Wize Pharma's official website?

The official website for Wize Pharma is http://www.wizepharma.com/.

How can I contact Wize Pharma?

Wize Pharma's mailing address is 24 HANAGAR STREET, HOD HASHARON L3, 4527708. The company can be reached via phone at 9724722600536.

MarketBeat Community Rating for Wize Pharma (OTCMKTS WIZP)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  50 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  83
MarketBeat's community ratings are surveys of what our community members think about Wize Pharma and other stocks. Vote "Outperform" if you believe WIZP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WIZP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel